The effect of donepezil on the cognitive ability early in the course of recovery from traumatic brain injury

References

• Centers for Disease Control and Prevention. Report to Congress on Traumatic Brain Injury in the United States: Epidemiology and Rehabilitation. Atlanta, GA: National Center for Injury Prevention and Control; Division of Unintentional Injury Prevention; 2015.
   Google Scholar
• Selassie AW, Zaloshnja E, Langlois JA, Miller T, Jones P, Steiner C. Incidence of long-term disability following traumatic brain injury hospitalization, United States, 2003. J Head Trauma Rehabil. 2008;23(2):123–31.
   PubMed Web of Science ®Google Scholar
• Zaloshnja E, Miller T, Langlois JA, Selassie AW. Prevalence of long-term disability from traumatic brain injury in the civilian population of the United States, 2005. J Head Trauma Rehabil. 2008;23(6):394–400.
   PubMed Web of Science ®Google Scholar
• Thurman DJ, Alverson C, Dunn KA, Guerrero J, Sniezek JE. Traumatic brain injury in the United States: a public health perspective. J Head Trauma Rehabil. 1999;14(6):602–15.
   PubMed Web of Science ®Google Scholar
• Rabinowitz AR, Levin HS. Cognitive sequelae of traumatic brain injury. Psychiatr Clin North Am. 2014;37(1):1–11.
   PubMed Web of Science ®Google Scholar
• NIH Consensus Development. Panel on rehabilitation of persons with Traumatic Brain Injury. Rehabilitation of persons with traumatic brain injury. JAMA. 1999;282(10):974–83.
   PubMed Web of Science ®Google Scholar
• Arciniegas D, Adler L, Topkoff J, Cawthra E, Filley CM, Reite M. Attention and memory dysfunction after traumatic brain injury: cholinergic mechanisms, sensory gating, and a hypothesis for further investigation. Brain Inj. 1999;13(1):1–13.
   PubMed Web of Science ®Google Scholar
• Diaz-Arrastia R, Kochanek PM, Bergold P, Kenney K, Marx CE, Grimes CJ, Loh LT, Adam LT, Oskvig D. Curley KC and others. Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup. J Neurotrauma. 2014;31(2):135–58.
   PubMed Web of Science ®Google Scholar
• Novack TA, Dillon MC, Jackson WT. Neurochemical mechanisms in brain injury and treatment: a review. J Clin Exp Neuropsychol. 1996;18(5):685–706.
   PubMed Web of Science ®Google Scholar
• Kim YW, Kim DY, Shin JC, Park CI, Lee JD. The changes of cortical metabolism associated with the clinical response to donepezil therapy in traumatic brain injury. Clin Neuropharmacol. 2009;32(2):63–68.
   PubMed Web of Science ®Google Scholar
• Arciniegas DB. The cholinergic hypothesis of cognitive impairment caused by traumatic brain injury. Curr Psychiatry Rep. 2003;5(5):391–99.
   PubMedGoogle Scholar
• Zhang L, Plotkin RC, Wang G, Sandel ME, Lee S. Cholinergic augmentation with donepezil enhances recovery in short-term memory and sustained attention after traumatic brain injury. Arch Phys Med Rehabil. 2004;85(7):1050–55.
   PubMed Web of Science ®Google Scholar
• Woolf PD, Hamill RW, Lee LA, Cox C, McDonald JV. The predictive value of catecholamines in assessing outcome in traumatic brain injury. J Neurosurg. 1987;66(6):875–82.
   PubMed Web of Science ®Google Scholar
• Donnemiller E, Brenneis C, Wissel J, Scherfler C, Poewe W, Riccabona G, Wenning GK. Impaired dopaminergic neurotransmission in patients with traumatic brain injury: a SPECT study using 123I-beta-CIT and 123I-IBZM. Eur J Nucl Med. 2000;27(9):1410–14.
   PubMedGoogle Scholar
• Eghwrudjakpor PO, Miyake H, Kurisaka M, Mori K. Central nervous system bioaminergic responses to mechanical trauma. An experimental study. Surg Neurol. 1991;35(4):273–79.
   PubMedGoogle Scholar
• Porta M, Bareggi SR, Collice M, Assael BM, Selenati A, Calderini G, Rossanda M, Morselli PL. Homovanillic acid and 5-hydroxyindole-acetic acid in the csf of patients after a severe head injury. II. Ventricular csf concentrations in acute brain post-traumatic syndromes. Eur Neurol. 1975;13(6):545–54.
   PubMed Web of Science ®Google Scholar
• Van Woerkom TC, Teelken AW, Minderhous JM. Difference in neurotransmitter metabolism in frontotemporal-lobe contusion and diffuse cerebral contusion. Lancet. 1977;1(8015):812–13.
   PubMed Web of Science ®Google Scholar
• Dixon CE, Liu SJ, Jenkins LW, Bhattachargee M, Whitson JS, Yang K, Hayes RL. Time course of increased vulnerability of cholinergic neurotransmission following traumatic brain injury in the rat. Behav Brain Res. 1995;70(2):125–31.
   PubMed Web of Science ®Google Scholar
• Saija A, Hayes RL, Lyeth BG, Dixon CE, Yamamoto T, Robinson SE. The effect of concussive head injury on central cholinergic neurons. Brain Res. 1988;452(1–2):303–11.
   PubMed Web of Science ®Google Scholar
• Whitlock JA Jr. Brain injury, cognitive impairment, and donepezil. J Head Trauma Rehabil. 1999;14(4):424–27.
   PubMed Web of Science ®Google Scholar
• Selden NR, Gitelman DR, Salamon-Murayama N, Parrish TB, Mesulam MM. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain. 1998;121(Pt 12):2249–57.
   PubMed Web of Science ®Google Scholar
• Blokland A. Acetylcholine: a neurotransmitter for learning and memory? Brain Res Brain Res Rev. 1995;21(3):285–300.
   PubMedGoogle Scholar
• Aigner TG. Pharmacology of memory: cholinergic-glutamatergic interactions. Curr Opin Neurobiol. 1995;5(2):155–60.
   PubMedGoogle Scholar
• Sarter M, Bruno JP. Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res Rev. 1997;23(1–2):28–46.
   PubMed Web of Science ®Google Scholar
• Ballesteros J, Guemes I, Ibarra N, Quemada JI. The effectiveness of donepezil for cognitive rehabilitation after traumatic brain injury: a systematic review. J Head Trauma Rehabil. 2008;23(3):171–80.
   PubMed Web of Science ®Google Scholar
• Chen Y, Shohami E, Bass R, Weinstock M. Cerebro-protective effects of ENA713, a novel acetylcholinesterase inhibitor, in closed head injury in the rat. Brain Res. 1998;784(1–2):18–24.
   PubMed Web of Science ®Google Scholar
• Yoo JH, Valdovinos MG, Williams DC. Relevance of donepezil in enhancing learning and memory in special populations: a review of the literature. J Autism Dev Disord. 2007;37(10):1883–901.
   PubMed Web of Science ®Google Scholar
• Levin HS, Peters BH, Kalisky Z, High WM Jr., Von Laufen A, Eisenberg HM, Morrison DP, Gary HE Jr. Effects of oral physostigmine and lecithin on memory and attention in closed head-injured patients. Cent Nerv Syst Trauma. 1986;3(4):333–42.
   PubMedGoogle Scholar
• Cardenas DD, McLean A Jr., Farrell-Roberts L, Baker L, Brooke M, Haselkorn J. Oral physostigmine and impaired memory in adults with brain injury. Brain Inj. 1994;8(7):579–87.
   PubMed Web of Science ®Google Scholar
• Walker W, Seel R, Gibellato M, Lew H, Cornis-Pop M, Jena T, Silver T. The effects of Donepezil on traumatic brain injury acute rehabilitation outcomes. Brain Inj. 2004;18(8):739–50.
   PubMed Web of Science ®Google Scholar
• McLean A Jr., Stanton KM, Cardenas DD, Bergerud DB. Memory training combined with the use of oral physostigmine. Brain Inj. 1987;1(2):145–59.
   PubMedGoogle Scholar
• Masanic CA, Bayley MT, VanReekum R, Simard M. Open-label study of donepezil in traumatic brain injury. Arch Phys Med Rehabil. 2001;82(7):896–901.
   PubMed Web of Science ®Google Scholar
• Wirkowski E, Prohovnik I, Young WL. Observations on the physostigmine syndrome in patients with Alzheimer’s disease. J Neuropsychiatry Clin Neurosci. 1991;3(1):73–75.
   PubMedGoogle Scholar
• Whelan FJ, Walker MS, Schultz SK. Donepezil in the treatment of cognitive dysfunction associated with traumatic brain injury. Ann Clin Psychiatry. 2000;12(3):131–35.
   PubMedGoogle Scholar
• Kaye NS, Townsend JB 3rd, Ivins R. An open-label trial of donepezil (aricept) in the treatment of persons with mild traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2003;15(3):383–84; author reply 384–5.
   PubMed Web of Science ®Google Scholar
• Morey CE, Cilo M, Berry J, Cusick C. The effect of Aricept in persons with persistent memory disorder following traumatic brain injury: a pilot study. Brain Inj. 2003;17(9):809–15.
   PubMed Web of Science ®Google Scholar
• Khateb A, Ammann J, Annoni JM, Diserens K. Cognition-enhancing effects of donepezil in traumatic brain injury. Eur Neurol. 2005;54(1):39–45.
   PubMed Web of Science ®Google Scholar
• Taverni JP, Seliger G, Lichtman SW. Donepezil medicated memory improvement in traumatic brain injury during post acute rehabilitation. Brain Inj. 1998;12(1):77–80.
   PubMed Web of Science ®Google Scholar
• Bourgeois JA, Bahadur N, Minjares S. Donepezil for cognitive deficits following traumatic brain injury: a case report. J Neuropsychiatry Clin Neurosci. 2002;14(4):463–64.
   PubMed Web of Science ®Google Scholar
• Sugden SG, Kile SJ, Farrimond DD, Hilty DM, Bourgeois JA. Pharmacological intervention for cognitive deficits and aggression in frontal lobe injury. Neuro Rehabil. 2006;21(1):3–7.
   Google Scholar
• Trovato M, Slomine B, Pidcock F, Christensen J. The efficacy of donepezil hydrochloride on memory functioning in three adolescents with severe traumatic brain injury. Brain Inj. 2006;20(3):339–43.
   PubMed Web of Science ®Google Scholar
• Foster M, Spiegel DR. Use of donepezil in the treatment of cognitive impairments of moderate traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2008;20(1):106.
   PubMed Web of Science ®Google Scholar
• Samuel GS, Ng YS. A case report on the use of an acetylcholinesterase inhibitor (donepezil) in traumatic brain injury. Med J Malaysia. 2013;68(4):376–78.
   PubMedGoogle Scholar
• Rogers SL, Doody RS, Mohs RC, Friedhoff LT. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med. 1998;158(9):1021–31.
   PubMed Web of Science ®Google Scholar
• Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery: theory and Clinical Interpretation. Tucson, AZ: Neuropsychology Press; 1985.
   Google Scholar
• Salthouse TA. What cognitive abilities are involved in trail-making performance? Intelligence. 2011;39(4):222–32.
   PubMed Web of Science ®Google Scholar
• Wechsler D. Wechsler adult intelligence scale - Fourth Edition. San Antonio, TX: The Psychological Corporation; 2008.
   Google Scholar
• Delis D, Kramer J, Kaplan E, Ober B. The California verbal learning test - second edition (CVLT-II). San Antonio, TX: The Psychological Corporation; 2000.
   Google Scholar
• Wechsler D. Wechsler Memory Scale - Fourth Edition. San Antonio, TX: Pearson; 2008.
   Google Scholar
• Williams MW, Smith EL. Clinical utility and psychometric properties of the Disability Rating Scale with individuals with traumatic brain injury. Rehabil Psychol. 2017;62(3):407–08.
   PubMed Web of Science ®Google Scholar
• Hamilton BB, Laughlin JA, Fiedler RC, Granger CV. Interrater reliability of the 7-level functional independence measure (FIM). Scand J Rehabil Med. 1994;26(3):115–19.
   PubMedGoogle Scholar
• Brown H, Prescott R. Applied mixed models in medicine. Hoboken, NJ: John Wiley & Sons; 2015.
   Google Scholar
• D’Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17(19):2265–81.
   PubMed Web of Science ®Google Scholar
• Liepert J. Pharmacotherapy in restorative neurology. Curr Opin Neurol. 2008;21(6):639–43.
   PubMed Web of Science ®Google Scholar
• Liepert J. Update on pharmacotherapy for stroke and traumatic brain injury recovery during rehabilitation. Curr Opin Neurol. 2016;29(6):700–05.
   PubMed Web of Science ®Google Scholar